Medicare Enrolled

Dr. Srinivas Gaddam, MD

Gastroenterology · West Hollywood, CA
Practice pattern: Interventional & Cardiac — Practice combining interventional and cardiac services
Low-engagement
8700 BEVERLY BLVD, West Hollywood, CA 90048
3101235000
In practice since 2007 (18 years)
NPI: 1982815262 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gaddam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gaddam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gaddam

Dr. Srinivas Gaddam is a gastroenterology specialist in West Hollywood, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Gaddam performed 639 Medicare services across 478 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gaddam received a total of $504 from 5 pharmaceutical and/or device companies across 8 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gaddam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 639 Medicare services $504 industry payments

Medicare Practice Summary

Medicare Utilization ↗
639
Medicare services
Bottom 45% in CA for gastroenterology
478
Unique beneficiaries
$150
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~36 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Stent replacement in pancreatic or bile duct
A flexible endoscope is used to remove an existing stent and insert a new one into the pancreatic or bile duct.
113 $292 $1,730
Radiologist review of bile duct tube placement imaging
A radiologist reviews images taken during the placement of a tube into the bile duct using an endoscope.
98 $20 $115
Pancreatic or bile duct stent insertion
A flexible endoscope is used to place a stent into the pancreatic or bile duct to keep it open.
75 $284 $1,660
Endoscopic removal of bile or pancreatic duct stone
A flexible endoscope is used to remove stones or debris from the bile or pancreatic ducts.
67 $71 $1,551
Endoscopic ultrasound of esophagus, stomach, or small bowel
An ultrasound exam of the esophagus, stomach, and/or upper small bowel performed using a flexible endoscope inserted through the mouth.
54 $130 $738
Ultrasound-guided esophageal needle biopsy
A procedure using a flexible endoscope with ultrasound to guide a needle for sampling tissue from the esophagus.
49 $161 $934
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
48 $47 $575
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
23 $74 $321
Balloon dilation of pancreatic or bile duct
A procedure using a flexible endoscope to widen a narrowed pancreatic or bile duct with a balloon. This helps restore the flow of digestive fluids.
20 $143 $1,381
Endoscopic ultrasound-guided needle biopsy
A procedure using an ultrasound-equipped endoscope to guide a needle for tissue sampling of the esophagus, stomach, or upper small bowel.
16 $203 $1,190
Endoscopic ultrasound of esophagus, stomach, or upper small bowel
An ultrasound exam of the esophagus, stomach, and/or upper small bowel performed using a flexible endoscope.
15 $166 $892
Endoscopic removal of foreign body from esophagus, stomach, or upper small bowel
A flexible endoscope is used to locate and remove a foreign object from the esophagus, stomach, or upper small intestine.
14 $111 $1,242
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
13 $51 $306
Endoscopic removal of pancreatic or bile duct stent
A flexible endoscope is used to remove a stent from the pancreatic or bile duct. This procedure accesses the ducts internally to extract the device.
12 $317 $1,371
Endoscopic biopsy of gallbladder, pancreas, liver, and bile ducts
A procedure using a flexible endoscope to collect tissue samples from the gallbladder, pancreas, liver, and bile ducts for examination.
11 $14 $1,196
Endoscopic incision of pancreatic outlet
A procedure where a flexible endoscope is used to make an incision in the pancreatic outlet.
11 $104 $1,353
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
31.3% high complexity
45.5% medium
23.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$504
Total received (2020-2024)
Avg $126/year across 4 years
Bottom 30% in CA for gastroenterology
5
Companies
8
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$504 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$205
2023
$201
2021
$70
2020
$29

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
FUJIFILM Healthcare Americas Corporation
$67
Medtronic, Inc.
$65
Boston Scientific Corporation
$42
Olympus America Inc.
$30
Top 3 companies account for 85.2% of 2024 payments
All-time payments by company (2020-2024) ›
Medtronic, Inc.
$209
Boston Scientific Corporation
$128
BOSTON SCIENTIFIC CORPORATION
$70
FUJIFILM Healthcare Americas Corporation
$67
Olympus America Inc.
$30
Top 3 companies account for 80.7% of all-time payments
Associated products mentioned in payments ›
EVIS EUS ENDOSCOPIC ULTRASOUND CENTER · EXALT MODEL D CONTROLLER · FUJIFILM · GENERAL - THERAPIES · NEXPOWDER · PRODIGI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a gastroenterology specialist in West Hollywood?
Compare gastroenterologists in the West Hollywood area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
475
Per 100K population
4.8
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gaddam is an interventional & cardiac specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gaddam experienced with stent replacement in pancreatic or bile duct?
Based on Medicare claims data, Dr. Gaddam performed 113 stent replacement in pancreatic or bile duct services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gaddam receive payments from pharmaceutical companies?
Yes. Dr. Gaddam received a total of $504 from 5 companies across 8 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gaddam's costs compare to other gastroenterologists in West Hollywood?
Dr. Gaddam's average Medicare payment per service is $150. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gaddam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →